LCM Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Buy
245
+27
+12% +$27.6K 0.13% 87
2026
Q1
$201K Buy
218
+10
+5% +$10.1K 0.1% 102
2025
Q4
$224K Buy
+208
New +$199K 0.11% 95
2025
Q3
Sell
-448
Closed -$349K 112
2025
Q2
$349K Buy
448
+1
+0.2% +$777 0.18% 71
2025
Q1
$369K Buy
447
+30
+7% +$25K 0.22% 63
2024
Q4
$322K Buy
+417
New +$345K 0.18% 68

Other funds holding LLY

LCM Capital Management's LLY Position: Q2 2026 in Review

LCM Capital Management increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $27.6K and bringing the position to 245 shares worth $294K. The position accounts for 0.13% of the portfolio, ranked #87.

LCM Capital Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $369K in Q1 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LCM Capital Management held 245 shares of Eli Lilly worth $294K as of Q2 2026.
  • LCM Capital Management bought 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 0.13% of LCM Capital Management's portfolio in Q2 2026, its #87 holding.
  • LCM Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • LCM Capital Management's Eli Lilly position peaked at $369K in Q1 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LCM Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.